SOPHiA GENETICS SA IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| SOPHiA GENETICS SA | SOPH - NASDAQ |
$17.00-$19.00 | $18.00 | $18.45 | 13 million | 7/23/2021 |
| J.P. Morgan, Morgan Stanley, Cowen, Credit Suisse | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-07-02 Terms Added 2021-07-19 | ||||||
SOPHiA GENETICS SA Quote & Chart - Click for current quote - SOPH
IPO Boutique aggregates information on public companies and private companies, such as "SOPH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About SOPHiA GENETICS SA (adapted from SOPHiA GENETICS SA prospectus):
They are a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "SOPH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.